| CAS NO. |
Products Name |
| 1350514-68-9 |
MK5172 |
more... |
| MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development |
|
|
|
| 701213-36-7 |
BMS626529 |
more... |
| BMS-626529 is a novel small-molecule attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T-cells. |
|
| 869901-69-9 |
MK2048 |
more... |
| MK-2048 is a potent inhibitor of integrase and INR263K with IC50 of 2.6 nM and 1.5 nM, respectively. |
|
| 1051375-10-0 |
Cabotegravir (GSK1265744) |
more... |
| Cabotegravir is a potent HIV integrase inhibitor as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV infection. Cabotegravir is an inhibitor of OAT1 (IC50 0.81 μM) and OAT3 (IC50 0.41 μM). |
|
| 144217-65-2 |
YYA-021 |
more... |
| YYA-021 is a small-molecule CD4 mimic that inhibits HIV entry, with high anti-HIV activity and low cytotoxicity. |
|
| 174022-42-5 |
Bevirimat（PA-457） |
more... |
| Bevirimat(YK FH312; FH11327; MPC-4326) is an anti-HIV drug derived from a betulinic acid-like compound; is believed to inhibit HIV by a novel mechanism, so-called maturation inhibition. |
|
|
|
|
|
|
|
| 1234480-46-6 |
XMD8-87 |
more... |
| XMD8-87 is a potent TNK2 inhibitor with IC50 values of 38 and 113 nM for the D163E and R806Q mutations, respectively. |
|
| 1345098-78-3 |
XMD16-5 |
more... |
| XMD16-5 is a potent TNK2 inhibitor with IC50 values of 16 and 77 nM for the D163E and R806Q mutations, respectively. |
|
All Products
